Gotham Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-61,725
Closed -$11.1M 1132
2017
Q3
$11.1M Buy
61,725
+56,405
+1,060% +$7.86M 0.16% 200
2017
Q2
$552K Buy
+5,320
New +$434K 0.01% 725

Gotham Asset Management's KITE Position: Q4 2017 in Review

Gotham Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 61,725 shares — an estimated $11.1M sold.

Gotham Asset Management first reported a position in KITE in Q2 2017 and held it in 2 quarters. The position peaked at $11.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Gotham Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Gotham Asset Management sold 61,725 Kite Pharma, Inc. shares in Q4 2017, an estimated $11.1M.
  • Gotham Asset Management first reported a position in Kite Pharma, Inc. in Q2 2017 and held it in 2 quarters.
  • Gotham Asset Management's Kite Pharma, Inc. position peaked at $11.1M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Gotham Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.